Prescription Drug Price Transparency
- Prescription Drug Price Transparency Home
- Reporting Resources
- Drugs of Substantial Public Interest Lists
- Research and Analysis
- Data and Dashboards
- Publications
- For Reporting Entities
Related Sites
Prescription Drug Price Transparency
The Minnesota Legislature passed the Minnesota Prescription Drug Price Transparency Act (Minnesota Statutes 62J.84) to increase transparency into the pricing and cost drivers of prescription drugs. The program is the first in the nation to collect prescription drug pricing data from drug manufacturers, wholesalers, pharmacy benefit managers, and pharmacies and make it available to the public.
The Minnesota Department of Health (MDH) is directed to collect and publish these data. The transparency data, interactive dashboards, research and analysis, reporting resources, and reports to the legislature are all available here online. This work supports the Legislature’s goals specified in the Act:
- Promote transparency in pharmaceutical pricing in Minnesota.
- Enhance the understanding of pharmaceutical spending trends.
- Assist the state and other payers in the management of pharmaceutical costs.
Sign up for email updates to receive news and notifications.
Get Reporting Guidance
Reporting entities should use the Reporting Resources page for technical and subject matter guidance.
Explore Research
Visit the Research and Analysis home page to find MDH summaries and analyses of prescription drug pricing data.
Provide Input
Share your experience with paying for and accessing prescription drugs or suggest areas of the prescription drug market to research on the Public Input page.